Fabio Lievano, MD - Biography
Fabio Lievano, MD
Vice President, Patient Safety, Scientific Collaborations and New Business Advancements, Pharmacovigilance & Patient Safety, Epidemiology and R&D Quality Assurance, AbbVie
Fabio Lievano, MD, serves as the vice president Patient Safety, Scientific Collaborations and New Business Advancements of AbbVie pharmaceuticals. He is an affiliate professor in molecular pharmacology and neuroscience at Loyola University Chicago’s Stritch School of Medicine and an adjunct associate professor in the Department of Pharmacology at Northwestern University.
Dr. Lievano obtained a Doctor of Medicine and Surgery degree from the National University in Bogota, Colombia, in 1992. He then completed an Epidemiology fellowship at the CDC Epidemic Intelligence Service in 2000.
At AbbVie, Dr. Lievano is responsible for a group of scientists and investigators in different disciplines assessing the benefit-risk of medicines during development and after post-marketing. In addition, he is a board member for the Respiratory Health Association a public health organization in Chicago and scientific advisor for Briya a data research company.
Dr. Lievano has previously worked at Merck Research Laboratories, Novartis Pharmaceuticals Corporation, Sanofi, Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), UNICEF/International Medical Corps, Castillo & Associates Medical Center, and the Clinic of Colombian Diabetes Association.
Fabio Lievano, MD, serves as the vice president Patient Safety, Scientific Collaborations and New Business Advancements of AbbVie pharmaceuticals. He is an affiliate professor in molecular pharmacology and neuroscience at Loyola University Chicago’s Stritch School of Medicine and an adjunct associate professor in the Department of Pharmacology at Northwestern University.
Dr. Lievano obtained a Doctor of Medicine and Surgery degree from the National University in Bogota, Colombia, in 1992. He then completed an Epidemiology fellowship at the CDC Epidemic Intelligence Service in 2000.
At AbbVie, Dr. Lievano is responsible for a group of scientists and investigators in different disciplines assessing the benefit-risk of medicines during development and after post-marketing. In addition, he is a board member for the Respiratory Health Association a public health organization in Chicago and scientific advisor for Briya a data research company.
Dr. Lievano has previously worked at Merck Research Laboratories, Novartis Pharmaceuticals Corporation, Sanofi, Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), UNICEF/International Medical Corps, Castillo & Associates Medical Center, and the Clinic of Colombian Diabetes Association.